Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference, held each year by the American Association for Cancer Research (AACR), the National Cancer Institute (NCI), and the European Organisation for Research and Treatment of Cancer (EORTC), brings together some of the world’s leading cancer scientists to discuss the discovery, biology, and clinical applications of novel cancer therapeutics.
Charles Swanton, FRCP, MD, PhD, of the Francis Crick Institute and UCL Cancer Institute in London, served as EORTC co-chair of the meeting’s Scientific Committee. Fellow co-chairs of the Scientific Committee were Antoni Ribas, MD, PhD, of UCLA Medical Center, representing the AACR, and James Gulley, MD, PhD, representing the NCI.
In this video, Swanton discusses how advances in cancer research have led to new areas for therapeutic exploration, as researchers work to understand how genomic data can be used to better understand tumors, and the challenges with increasing the number of patients who could benefit from promising new immunotherapeutic drugs.
Swanton said the multidisciplinary nature of the presentations, combined with the international expertise of the participants, contributes to a robust program. For more information on the conference, see our website. Follow the meeting on Twitter at #Targets17.
You may also like: